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ABSTRACT 
 
The dangers of secondhand smoke (SHS) exposure on the human body were initially 
reported in 1972, just eight years after the negative effects of smoking on smokers was 
reported. The Surgeon General of the United States systematically expanded (and 
continues to expand) the warnings over time, as new scientific evidence becomes 
available. Warnings, which began to incorporate youths in 1975, emphasized the need to 
pay particular attention to fetuses, newborns, infants, children, adolescents, and young 
adults since they rely on parents, guardians, and other adults to keep them safe. Although 
fewer in number than adults, the diseases that are causally linked to smoking and 
exposure to SHS in youths are also complex and can result in death (i.e., sudden infant 
death syndrome). The introduction of new tobacco products, such as low nicotine 
cigarettes and electronic cigarettes, prompted the Surgeon General to release additional 
warnings. In 2016, the Surgeon General advised the nation that more information will 
become available as the electronic cigarette manufacturers comply with new Tobacco 
Control Act requirements to report harmful vapor constituents. Physicians need to keep 
abreast of the vast and growing body of knowledge related to the biological and chemical 
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components of SHS and vapor, as well as the dangers that SHS and vapor cause. To ease 
the burden on physicians, the federal government and medical professional societies 
created clinical practice guidelines which summarize the literature related to the dangers 
of SHS and make recommendations for medical management. Guidelines recommend 
that physicians and other clinicians should offer smoking cessation advice and intervene 
to limit youth exposure to SHS. Although the approach recommended for use with 
patients in a physician’s office is clear and attempts to streamline the processes have been 
made, the identification and counseling process for smoking cessation and eliminating 
SHS exposure remains time consuming.  Barriers to payment make it difficult for 
physicians to be adequately reimbursed for their efforts to keep their patients safe from 
the dangers of SHS and vapor exposure. More work is needed to be able to continue to 
reduce the percentage of youths exposed to SHS in their environments. Additional 
attention is needed to address the racial and ethnic disparities that are evident in the 
scientific literature. 
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Introduction 
 Definition of SHS and Vapor 
Secondhand smoke (SHS) includes smoke released into the atmosphere through 
the smoking of traditional cigarettes and other tobacco products such as cigars and pipe 
tobacco. SHS smoke is a combination of sidestream smoke that is emitted from the 
burning end of a cigarette or other tobacco product, as well as the mainstream smoke 
exhaled by the smoker1. Other terms for SHS and SHS exposure include environmental 
smoke/smoking, passive smoke/smoking, and involuntary smoke/smoking. 
Historically, the amount of SHS exposure from traditional tobacco products 
varied based on four factors: 1) the amount of smoke produced by the individual(s) 
smoking (e.g., number of cigarettes smoked and time spent in the area); 2) the depth of 
the inhalation by the smoker(s); 3) the distance between the smoker(s) and the exposed 
individual; and 4) the ventilation in the area1. A fifth factor, the amount of nicotine in the 
cigarette, was added to the list when cigarettes with varying degrees of nicotine were 
introduced to the market2. 
Electronic cigarettes (i.e., e-cigarettes), which became commercially available in 
2003, involve the placement of nicotine and other liquid(s) (i.e., e-liquids) into an 
electronic device. The liquid is heated and “vaped” in a manner similar to the traditional 
smoking process used with regular cigarettes. While sidestream and mainstream smoke 
are released into the environment during traditional smoking, aerosol, or vapor, is 
released into the environment through mainstream vapor during vaping3. The amount of 
aerosolized nicotine released depends on factors such as the concentration of the liquid 
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nicotine used, the power of the device, and the duration of the puff and interval between 
puffs4,5.  Secondhand exposure to nicotine from smoking tobacco cigarettes is on average 
ten times higher than from e-cigarettes6. 
  
Composition of SHS and Vapor 
SHS is a complex mixture of more than 4,000 compounds; 40 of the compounds 
can cause cancer. Examples of the human carcinogens include 4-aminobiphenyl, 2-
naphthylamine, benzene, nickel, polycyclic aromatic hydrocarbons (PAHs), and N-
nitrosamines. There are irritants such as ammonia, nitrogen oxides, sulfur dioxide and 
various aldehydes. Cardiovascular toxicants, such as carbon monoxide and nicotine, are 
also among the list of harmful compounds7. 
In an abbreviated version of the 2006 report of the health consequences of SHS, 
the Surgeon General advised that SHS is toxic; it is comprised of cancer causing 
chemicals, toxic metals, and poison gases8. Figure 1 displays examples of these 
chemicals, metals, and gases.  
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Figure 1 – Chemical components of secondhand smoke. Figure taken from The 
Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the 
Surgeon General, Secondhand Smoke, What It Means to You, 20068 
 
 
In the 2010 report by the U.S. Department of Health and Human Services 
(DHHS), the Surgeon General reported that inhaled cigarette smoke and SHS includes 
more than 7,000 chemicals. Not only are the chemicals hazardous, but at least 69 of the 
chemicals can cause cancer2. 
According to the 2016 Surgeon General report on e-cigarettes, the emissions 
produced by vaping may include approximately 31 compounds, such as nicotine, 
nicotyrine, formaldehyde, acetaldehyde, carbonyl compounds, volatile organic 
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compounds, polyaromatic hydrocarbons, nitrosamines, heavy metals, acrolein, acetol, 
glycidol, and glycols9. The evidence of the level of harmful chemicals that are released 
through e-cigarette aerosol in relation to traditional cigarettes is still unclear. More 
information for consumers is expected to become available when manufacturers comply 
with the Tobacco Control Act.  
The Tobacco Control Act, which first went into effect in 2009, was extended in 
2016 to include requirements for e-cigarettes3. According to the expanded Tobacco 
Control Act, manufacturers of e-cigarettes need to comply with the same requirements as 
manufacturers of traditional cigarettes. The extension requires that e-cigarette companies 
must list all of the ingredients on all e-cigarette packages. They must display the same 
health warnings on their packaging as traditional cigarette boxes. They must not sell e-
cigarettes to anyone under the age of 18. Purchasers of e-cigarettes are required to show 
proof of adult age through photo identification. The regulation prevents the sale of e-
cigarettes through vending machines.  
The expanded Tobacco Control Act allows the Food and Drug Administration 
(FDA) to order that e-cigarette manufacturers reduce or eliminate any harmful ingredient 
or additive that might be harmful. The increased transparency about the components of e-
cigarettes is expected to encourage more attention and focus on the dangers of e-
cigarettes for the users, as well as for the individuals who are exposed to the aerosol 
produced through the vaping process. Although the 2016 regulation extension did not 
cover e-cigarette accessories, the regulation identified the plan to regulate items such as 
batteries, coils, and other accessories through future regulations. 
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Measurement of SHS and Vapor 
The measurement of SHS exposure involves the capture of subjective and 
objective measures. Similar to self-report measures of amount of cigarettes smoked by 
smokers (e.g., packs per day or pack years), measures such as hours per day exposed to 
environmental tobacco smoke (ETS) by nonsmokers, are difficult to determine and may 
not be accurate. The amount of the ETS exposure depends on multiple variables. The 
number of cigarettes being smoke by individuals in the area is a major factor, but is 
difficult to determine. The number can fluctuate on a continual basis. ETS exposure also 
depends on how close the occupants of the area are to the burning cigarettes. The room 
ventilation is an important variable that drives ETS exposure. There are individual 
differences in sensitivity to ETS. Individuals who are concerned about ETS exposure 
may be more likely to act in ways that reduce the amount of smoke that they inhale10. 
There is an alternative to using self-report measures to determine exposure to 
ETS. Concentrations of a component of smoke can be measured in the body fluids of an 
exposed individual through biologic markers (i.e., biomarkers)10. Cotinine is the major 
proximate metabolite of nicotine and is considered the recommended biomarker for 
determining the amount of secondhand smoke exposure8. Cotinine is found in the blood, 
urine, saliva, and hair of those who are exposed to tobacco smoke through smoking and 
exposure to SHS. The Surgeon General advised, however, that individual biomarkers 
such as cotinine do not adequately represent the components of SHS that might be 
present in the blood and body fluids. They caution that there are other dangerous 
substances that could be measured by other biomarkers8. Despite the limitations, cotinine 
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is considered by researchers and experts to be a reliable and valid measure of average 
human SHS exposure over time. Cotinine is reported in the scientific literature to be the 
best available biomarker of SHS exposure10. Cotinine is also used to measure nicotine in 
those who use e-cigarettes and are exposed to e-cigarette vape. 
Both subjective and objective measures, including cotinine, have been used to 
study the effect of SHS exposure in children, which is the focus population for this 
review. Cotinine levels have been shown to be positively correlated to health problems in 
children10. 
 
Effects of SHS and Vapor on the Body 
The Surgeon General has advised throughout the years that tobacco smoke 
damages organs in the body, causes disease, and can even result in death2. Figure 2 
demonstrates the organs affected by both direct smoking and involuntary smoking in both 
adults and children. In youths, there is a causal relationship between secondhand smoking 
and four diseases and conditions: 1) middle ear disease; 2) impaired lung function; 3) 
lower respiratory illness; and 4) sudden infant death syndrome (SIDS). 
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Figure 2 – The health consequences causally linked to smoking and exposure to 
secondhand smoke. Figure taken from USDHHS, 2010, p. 42. 
 
 
 
As early as 1972, the Surgeon General warned the nation that respiratory 
symptoms, such as cough and wheezing, occur when nonsmoking individuals were 
exposed to tobacco smoke1. The respiratory system is the first system to come in contact 
with secondhand smoke and one of several systems that can be damaged by secondhand 
smoke8. In addition to being the first point of entry, the respiratory tract has a large area 
where SHS components can be deposited and absorbed into the body8. The Surgeon 
General concluded that maternal smoking affects the expiratory flow rates of fetuses by 
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restricting the lumens of smaller airways. The reduction in the diameter of the lumens 
cause increased airway resistance8. Cough and wheezing are symptoms of the restriction 
of airway lumens. 
SHS exposure also increases bronchial hyperactivity (BHR). Young et al. (1991) 
reported a modest increase in BHR from inhaled histamine in infants of parents who 
smoked compared to parents who did not smoke11. The increase in BHR is believed to be 
caused by an increase in the neuroendocrine cells in the lung. Neuroendocrine cells, 
which are located in the epithelium of the airway, synthesize and release 
bronchoconstrictors, which include serotonin, endothelin, and bombesin8. 
Secondhand smoke exposure affects the neural control of airways. Sensory 
nonmyelinated bronchopulmonary C-fibers become stimulated, which triggers intense 
respiratory responses through local and lung C-fiber central nervous system reflexes8. 
The respiratory symptoms that occur are similar to those seen with asthma, including 
bronchoconstriction and excessive mucous production. 
Geng et al. (1995) described the mechanism that produces pulmonary infection in 
individuals exposed to secondhand smoke. Secondhand smoke can inhibit antibody 
responses that are either T cell-dependent or T cell-independent. Immune responses 
become impaired12. Nicotine induces a state of anergy in lymphocytes and may be related 
to their impaired immune response12. 
According to the Surgeon General, the science behind the underlying the 
increased risk of infection associated with secondhand smoke exposure is not fully 
understood8. The Surgeon General identified macrophage responsiveness, impairment of 
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mucociliary clearance, disruption of respiratory epithelium, and alteration of bacterial 
flora as mechanisms that cause infection in individuals exposed to secondhand smoke. 
Middle ear disease is caused by irritation of the eustachian tube from secondhand 
smoke. The tube connects the back of the nose with the middle ear. Irritation of the tube 
results in swelling and obstruction which, in turn, causes pressure problems in the middle 
ear. The build-up of pressure causes symptoms such as pain and fluid. The fluid can 
become infected and result in the diagnosis of otitis media8. 
Jordanov (1990) reported that fetuses are exposed to SHS. Increased cotinine 
levels were measured in the amniotic fluid of pregnant nonsmokers exposed to SHS. 
Cotinine was also found in the urine of their newborn infants on the first day of life13. 
Fetal development is impacted by carbon monoxide and/or nicotine14. Carbon monoxide 
decrease the oxygen-carrying capacity of hemoglobin. Hemoglobin has a higher affinity 
for carbon dioxide than it does for oxygen. Fetal hemoglobin has an even higher affinity 
for carbon monoxide than adult hemoglobin. Therefore, the impact of nicotine on the 
fetus is more severe than on the mother. Fetal tissues receive even less oxygen in the 
presence of nicotine. A reduction in placental perfusion leads to reduced fetal tissue 
oxygenation.  
Pregnant women who do not smoke, but are exposed to ETS, have an increased 
risk of delivering babies with lower birth weights. The average weight of babies born to 
women who are exposed to ETS is, on average, 35 Grams lower than babies born to 
women who are not exposed. The difference ranges from 10 to 110 Grams. Although the 
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differences do not demonstrate statistical significance, the lower weight is consistently 
evident in women who are exposed to ETS7.  
In 2011, the American Academy of Pediatrics Task Force on Sudden Infant Death 
reported that autonomic function and/or arousal that are caused by tobacco smoke could 
increase the risk of SIDS15. Schneider et al. (2008) showed an association between 
prenatal exposure to cigarette smoke and impaired recovery from hypoxia in preterm 
infants16. In a study on 22 smoking and nonsmoking mothers carrying infants between 28 
and 36 weeks’ gestation, Schneider measured cardiorespiratory variables. Schneider et al. 
(2008) reported that prenatal cigarette smoke exposure affects the recovery of breathing 
pauses and lowers oxygen saturation levels in preterm infants. Lower oxygen saturation 
places preterm infants at a high risk for developing SIDS16. 
In a sleep study, Richardson et al. (2009) measured daytime polysomnography at 
two to four weeks, two to three months, and five to six months postnatal age in full-term 
infants born to smoking and nonsmoking mothers17. The study measured physiologic and 
electroencephalogram changes following stimulation of the nostrils with air during sleep, 
in both supine and prone positions of infants17. The study concluded that in infants 
exposed to SHS, there was progression from sub-cortical activation to cortical arousal 
was depressed at two of the three measurements periods, including two to four weeks and 
five to six months. There was no effect of SHS produced by mothers at two to three 
months. The study identified a significant dose-dependent relationship between cortical 
activation proportions and urinary cotinine levels when infants were in both supine and 
prone positions17. The study concluded that maternal smoking is associated with impaired 
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arousal processes to stimulation of the nostrils with air during sleep and that may increase 
the risk for SIDS17. 
 The effect of the inhalation of secondhand vapor on the body is less understood 
than SHS from regular cigarettes. In 2016, the Surgeon General reported that nicotine 
crosses the placenta and has known effects on the development of fetuses and infants. 
The Surgeon General concluded that nicotine delivered by e-cigarettes during pregnancy 
can result in SIDS and could result in altered corpus callosum, auditory processing 
problems, and obesity3. 
 
SHS and Vapor Exposure in Youths 
 Dangers of SHS and Vapor Exposure in Youths  
The dangers of SHS exposure were first reported by Surgeon General in 19721, 
just eight years after the first report on the dangers of smoking on smokers was released. 
They included allergic and irritative reactions such as eye irritation, nasal symptoms, 
cough, and wheezing, and were reported in nonsmokers of various ages, including 
children. Warnings from the Surgeon General about the effects of SHS on children were 
extended in 197518, and again in 198419, to include diagnoses of pneumonia and 
bronchitis. In 1986, the Surgeon General added tracheitis and laryngitis to its list of 
warnings20. This report elevated the severity of the warning by documenting an increased 
frequency of hospitalization for bronchitis and pneumonia during the first year of life in 
newborns of smoking parents, as compared to newborns whose parents do not smoke. 
Middle ear effusions (e.g., otitis media) were also more common in children of smoking 
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parents, as compared to children of nonsmokers. Asthma symptoms are exacerbated by 
SHS in about 20 percent of the two to five million asthmatic children in the United 
States, according to the 1994 Surgeon General report21. Low birth weight and sudden 
infant death syndrome (SIDS) were also reported in children of smoking parents.   
In 2014, the Surgeon General concluded that there is sufficient evidence to infer a 
causal relationship between SHS exposure from parental smoking and 1) ever having 
asthma in children of school age; 2) chronic respiratory symptoms such as cough phlegm, 
wheeze, and dyspnea in children of school age; 3) lower respiratory illnesses such as 
pneumonia and bronchitis in infants and children; 4) middle ear disease, including acute 
and recurrent otitis media and chronic middle ear effusion, in children15. 
 
Prevalence of SHS and Vapor Exposure in Youths 
The number of children who are exposed to SHS is high. According to the World 
Health Organization (WHO), almost half of the world’s children, approximately 700 
million, breathe air that is polluted by tobacco smoke22. Twenty two percent of children 
younger than 18 years of age are exposed to secondhand smoke in their homes8. 
The National Health and Nutrition Examination Survey (NHANES) is a survey of 
the noninstitutionalized individuals throughout the United States and is conducted for a 
duration of two years in each cycle. A home interview, physical examination, and serum 
cotinine analysis are included for study participants of ages three and above23.  
During 2011-2012, the prevalence of SHS exposure, as defined by serum cotinine 
levels of 0.05-10 ng/mL used to determine SHS exposure, was highest (40.6%) in 
13 
 
children aged 3-11, followed by 33.8% in adolescents aged 12-19 years and 21.3% in 
adults aged 20 years and above. An estimated 15 million children aged 3-11 years were 
deemed to be exposed to SHS nationwide. SHS exposure among children aged 3–11 
years was significantly higher among non-Hispanic blacks (67.9%) than non-Hispanic 
whites (37.2%; p<0.05). SHS exposure among children aged 3-11 years was also 
significantly higher among Mexican Americans than non-Hispanic whites (29.9%; 
p<0.05)23. SHS exposure in adolescents aged 12–19 years and adults aged ≥20 years was 
significantly higher among non-Hispanic blacks (54.6% and 39.6%) than non-Hispanic 
whites (35.8% and 17.9%; p<0.05)23. 
NHANES reported that serum cotinine levels in nonsmokers aged 3 years and 
above declined by 51.8%, from 52.5% during 1999-2000 to 25.3% during 2011-201223. 
Table 1 demonstrates the change over time in the percentages of nonsmokers with serum 
cotinine levels reflective of SHS exposure, by age group and race/ethnicity. The percent 
reduction varies by race and age, and demonstrates the need to focus on minority youths. 
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Table 1 - Percentage of nonsmokers with serum cotinine levels 0.05–10 ng/mL, by 
age group and race/ethnicity* — National Health and Nutrition Examination 
Survey, United States, 1999–2012. Table taken from Homa et al., 2015, p. 10623. 
 
 
According to NHANES, there are disparities exist in SHS exposure based on 
socioeconomic status. Individuals with low socioeconomic status are exposed to SHS 
more than individuals who do not have a low socioeconomic status23. Declines in SHS 
exposure have been related to smoke-free laws that prohibit smoking in restaurants and 
other public places, adoption of smoke-free homes and vehicles, and a reduction in the 
number of smokers who emit SHS. Those who live in multiunit housing arrangements, 
many of whom live below the poverty level, are at risk for SHS exposure from smoke 
that infiltrates living spaces.    
The Environmental Protection Agency (EPA) estimated that annually between 
150,000 and 300,000 cases of bronchitis and pneumonia in infants and young children up 
to 18 months of age are attributable to environmental tobacco smoke (ETS), and 7,500 
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and 15,000 will result in hospitalization. Exposure to ETS worsens asthma in between 
200,000 and 1,000,000 children each year24. 
The effect of SHS on young people has received particular attention because 
youths often rely on parents, guardians, and others to keep them safe. The Pregnancy 
Risk Assessment Monitoring System (PRAMS) is a surveillance system that is used by 
numerous states throughout the nation. PRAMS monitors health behaviors of females 
before, during, and after pregnancy. Participant states randomly sample females each 
month during pregnancy. They also complete the questionnaires approximately four 
months after delivery25. A study of 135,278 mothers from 28 states who responded to 
PRAMS from 2000 to 2003 found SHS exposure in infants only a few months old. 
Nearly ten percent of mothers reported that her infant was in the same room as someone 
who smoked for more than one hour each day. Infants with siblings were more likely to 
be exposed to SHS for more than one hour each day than infants with no siblings25. 
SHS exposure was reported in 2001 by the American Academy of Pediatrics 
(AAP) to be a class-based epidemic with rates of 40 percent for children from families 
with low socioeconomic status and 20 percent for children from more educated and 
wealthier families26. The National Survey on Environmental Management of Asthma and 
Children’s Exposure to ETS reported that exposure is significantly higher in households 
at or below the poverty level and households with less than a college degree27. Infants 
and children born to white mothers and mothers with low educational attainment, 
unmarried mothers, and mothers on Women, Infants, and Children (WIC) support 
programs were more likely to be exposed to SHS21, 28, 29.  
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Physicians’ Role in Addressing Secondhand Smoke Exposure 
Physicians are in a position to protect patients and their families from SHS and 
vapor exposure in their daily professional activities. Physicians have knowledge of the 
composition of SHS and vapor, knowledge of the dangers associated with SHS smoke 
and vapor exposure, and are educated and trained to help patients and families reduce 
risky behaviors and promote health. They are guided in their practice by national 
guidelines and recommendations from professional medical organizations about 
assessment and management of secondhand smoke and vapor exposure. 
 
 National Guidelines 
In 1996, the Agency for Health Care Policy and Research (now AHRQ), a 
division of the U.S. Department of Health and Human Services, released a Clinical 
Practice Guideline known as Smoking Cessation, Clinical Practice Guideline No. 1830. 
This original guideline covered over 3,000 scientific articles related to tobacco 
dependence treatment and practices that were published between 1975 and 1994. The 
Guideline provided a framework for teaching medical physicians, administrators, and 
policymakers about the importance of tobacco dependence and its treatment.  
In June 2000, the U.S. Department of Health and Human Services, Public Health 
Service department released a Clinical Practice Guideline entitled Treating Tobacco Use 
and Dependence31. The guideline was created through a collaborative effort by several 
federal and nonprofit organizations. They included the Federal Government, AHRQ, 
Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), 
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National Heart, Lung, and Blood Institute (NHLBI), National Institute on Drug Abuse 
(NIDA), Robert Wood Johnson Foundation, and University of Wisconsin Medical 
School’s Center for Tobacco Research and Intervention31. The guideline summarized the 
clinical treatments for tobacco dependence that were published in 3,000 articles. Between 
1995 and 1999, another 3,000 were published and, together with the original 3,000, were 
utilized for the updated guideline. The updated guideline included the best of the total 
6,000 articles that were published to date, based on a metaanalysis of the literature. This 
guideline contains strategies and recommendations to help clinicians, tobacco 
dependence treatment specialists, insurers, and others to deliver and effective treatments 
for tobacco use and dependence31. 
The guideline concluded that providing information to parents regarding the 
dangers of secondhand smoke reduces childhood exposure to secondhand smoke. It also 
reduces parental smoking rates. The guideline includes a formal recommendation that 
advised practitioners in pediatric settings to offer smoking cessation advice and 
interventions to parents in order to reduce children’s exposure to SHS31. The strength of 
the evidence was rated with a letter B which signifies that there is some evidence from 
randomized clinical trials. The rating was not as strong as an A which means there are 
multiple well-designed randomized control trials, but is better than a rating of C which 
equates to no randomized controlled trials. 
The guideline also suggests that primary care clinicians intervene using a 5-Step 
process when they have a patient who is willing to quit smoking. Table 2 includes the 
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strategies which are reported to take approximately three minutes in the physicians’ 
office. 
Table 2 – The "5 A's" for brief intervention. Table taken from USDHHS, 2000, p. 
2631.
 
 
The 2008 Update32 to the Clinical Practice Guideline entitled Treating Tobacco 
Use and Dependence summarized 8700 English-language, peer-reviewed articles and 
abstracts related to the treatment of tobacco dependence that were published between 
1975 and 2007. The 2008 Update was created through another collaboration among 24 
scientists and clinicians from governmental and nonprofit organizations, including 
AHRQ, CDC, NCI, NHLBI, NIDA, Robert Wood Johnson Foundation, the Legacy 
Foundation, and the Center for Tobacco Research and Intervention at the University of 
Wisconsin School of Medicine and Public Health32. 
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The 2008 Update continued to encourage physicians to use a 5As Approach (Ask, 
Advise, Assess, Assist, Arrange Follow-up) in their assessment and follow-up of tobacco 
use in their patients. In the “Advise” step, clinicians are encouraged to link the use of 
tobacco to current symptoms, social and economic costs, and the dangers of tobacco use 
on children and others in the household32. They suggest that clinicians speak clearly, but 
be strong in their message. They advise that clinicians personalize the message of tobacco 
cessation when speaking with parents who smoke. The update recommends that 
physicians should give patients specific advice to quit smoking since it can reduce 
diseases associated with SHS. For example, a physician should talk about the link 
between SHS and ear infections if a child has ear infections associated with SHS32.  
The National Cancer Institute, a section of the National Institutes of Health (NIH), 
has been a leader in funding and supporting research related to smoking cessation. In 
2011, it launched the State and Community Tobacco Control (SCTC) Research Initiative. 
The initiative advocates the continued focus on expanding places that are smoke-free 
throughout the nation. The NCI, for example, only holds their own meetings and 
conferences in facilities in states that are smoke free33. 
 
Medical Society Positions 
Medical Societies are in an excellent position to offer specific recommendations 
to their physician membership on the methods to reduce exposure to SHS smoke and 
vapor. One such organization is the American Academy of Pediatrics (AAP), which is an 
organization comprised of 67,000 pediatricians committed to the care of infants, children, 
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adolescents, and young adults. In 2001, the AAP’s Committee on Substance Abuse 
advised its large membership that pediatricians have an important role in reducing 
tobacco use by youths and their parents. They also advised that SHS exposure should 
rank this among their highest prevention strategies26. 
AAP originally recommended a 6As approach to guide pediatricians in addressing 
tobacco use by children and adolescents (Anticipate, Ask, Advise, Assess, Assist, 
Arrange Follow-up), as defined by the U.S. Public Health Service. The first step, 
Anticipate, was an added to anticipate challenges. The AAP then supported the move to 
the 5As. To demonstrate the importance and commitment of the AAP to smoking, it 
created its own Section on Tobacco Control in 2012. The AAP emphasized that tobacco 
use is a pediatric disease and approximately half of the pediatric population is exposed to 
secondhand smoke34. In its 2015 Technical Report entitled Protecting Children from 
Tobacco, Nicotine, and Tobacco Smoke, the AAP recommended that pediatricians 
identify individuals who could benefit from counseling and smoking cessation treatments 
for parents who are dependent on smoking tobacco. AAP recommends that pediatricians 
use the Clinical Effort Against Secondhand Smoke Exposure (CEASE) program to 
protect youths35. 
CEASE was formed by Massachusetts Tobacco Cessation and Prevention 
Program, the Massachusetts General Hospital, and numerous AAP Chapter members, 
among others, to help practitioners organize processes in their offices to address parental 
tobacco use in a systematic manner36. Based on a randomized controlled clinical trial at 
20 physician practices, there were higher rates of identification and documentation of 
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parents who smoke, as well as use of smoking cessation materials by those parents who 
received printed materials, were shown the training video, were provided with short 
training phone calls, and received ongoing support through routine listserv emails, 
monthly newsletters, and monthly mailings of education materials. 
The CEASE program implemented a change from the 5As to 3As. Table 3 
describes the 3As and how the 5As were collapsed into 3As for easier learning and 
retention. The table demonstrates that the actual interventions under each step are 
unchanged.  
Table 3 – The 3As of Tobacco Cessation. Table taken from Winickoff et al., 
2012, p. 836. 
 
 
The American Academy of Family Physicians (AAFP) is the national association 
of family physicians and is one of the largest medical organizations in the nation. The 
AAFP is comprised of 131,400 members in 50 states, D.C., Puerto Rico, the Virgin 
Islands, Guam, and throughout the world. The AAFP encourages the prohibition of 
tobacco products in all public places. They encourage family physicians to advise their 
patients, especially those with cardiovascular diseases or other chronic disease, to avoid 
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places where people are smoking. They request that patients advise their family members 
to not smoke in the patient's home or vehicle. They advise that family physicians should 
encourage cessation of adult household members37. 
Because of the cumbersome and time-consuming nature of the 5As Approach, the 
AAFP, like the AAP, recommended an abbreviated intervention. The AAFP approach 
was even more succinct than AAP. The AAFP ASK and ACT Approach encourages 
family physicians to ASK all patients about tobacco use and then to ACT to help patients 
and family members quit. Although the acronym used is shorter and easier to recall, the 
AAFP continues to include the expanded steps in their guidance to family physicians. 
The AAFP suggests in their online practice manual that family physicians should ask if 
their patients smoke and take appropriate action if they do. They should advise their 
patients to quit and assisting those who are interested in quitting38. Table 4 demonstrates 
the 5As continue to be detailed in the AAFP physician practice manual. 
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Table 4 – The 5As of Tobacco Cessation. Table taken from AAFP, ASK and 
ACT: A Tobacco Cessation Program, p. 838. 
 
 
According to the AAP and the Policy Statement by the Committee on 
Environmental Health, Committee on Substance Abuse, Committee on Adolescence, and 
Committee on Native American Child Health, all clinical encounters provide an 
opportunity for clinicians to ask about SHS exposure, but they emphasized 
documentation of SHS exposure in the medical record.   
The American Academy of Family Physicians (AAFP) encourages the use of 
electronic health records (EHRs). EHRs should at least include a template that has a 
minimum of four items related to smoking, including 1) information about tobacco and 
nicotine use; 2) secondhand smoke exposure; 3) interest in smoking cessation; and 4) 
history of attempts to stop smoking. The EHR should also include automatic prompts that 
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encourage clinicians to focus on quitting with their patients, encourage smoke-free 
environments, and arrange smoking cessation interventions for patients and their families. 
 The EHR should be sophisticated enough to prompt the assessment and 
intervention questions when patients present for sick visits related to cough, upper 
respiratory problems, diabetes, ear infections, hypertension, asthma, and other conditions. 
The EHR should also prompt providers to assess and intervene each time a patient arrives 
for a well-visit39. The AAFP elements for electronic entry of secondhand smoke exposure 
is advised to include whether SHS is current, former, or never, as well as where the 
exposure occurs (e.g., home). 
Pediatricians and other clinicians are encouraged to advocate for tobacco-free 
homes, cars, schools, and other settings. The Policy Statement informs pediatricians that 
they should apply the applicable diagnosis codes for tobacco use or STS exposure and 
bill insurance companies for treatment of tobacco dependency. They also advise 
practitioners to record tobacco use and SHS exposure, when appropriate, on death 
certificates. They also suggest that practitioners record SHS exposure as the cause or as a 
contributor to death if applicable34. 
Recommendations from professional societies are no longer limited to smoking or 
regular cigarettes. Recommendations for cessation of e-cigarettes have been added in 
recent years. The AAP, the AAFPs, the American College of Physicians, the American 
College of Obstetricians and Gynecologists, and the American Medical Association 
joined together in support of the Surgeon General’s report of the dangers associated with 
e-cigarette use in youths and young adults. They called on their physician members to 
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advise parents and family members who smoke about the risks of e-cigarette use and SHS 
exposure, encourage them not to use any tobacco products around youths, and encourage 
them to quit smoking40. 
 
Physician Advocacy Role 
In addition to their role in reducing SHS and vapor exposure in patients and 
families in their offices, physicians have a major impact through their roles on national 
and local task forces and committees. The Surgeon General, who is required to be a 
licensed physician in the United States, is an example of such a role. Eight of the 15 
members of the Community Preventive Services Task Force (CPSTF) members, who are 
appointed by the Director of the CDC, are physicians. The CPSTF is an independent, 
nonfederal group of public health experts that provides evidence-based research and 
recommendations about community prevention services and interventions designed to 
improve the health of populations41. The task force focuses on the implementation of 
smoke-free policies to reduce SHS and vapor exposure. On a local level, physicians can 
participate in community health and disease prevention events, hospital and healthcare 
organization committees and task forces, and more. 
 
Barriers to Reducing Secondhand Smoke and Vapor Exposure 
 Resistance from the Tobacco Industry 
 The United States uses a system known as the International Classification of 
Diseases (ICD) Clinical Modification (CM) coding system42 to identify causes of injury 
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and illness. The system is necessary to organize statistics so that they can be used to 
further public health research and practices. An external code (commonly referred to as 
an E code) is a diagnosis code used to classify environmental events, circumstances, and 
conditions as the cause of injury, poisoning, or other adverse events. E code 869.4, which 
designates Second-hand Tobacco Smoke, was first published in the 9th version of the 
ICD-CM manual in October 1994 and was listed in the accidental poisoning by other 
gases and vapors section. E codes are intended to be used in conjunction with an ICD-9-
CM diagnosis code. A patient admitted to a hospital with bronchitis, for example, and has 
documentation in the medical record that supports tobacco smoke exposure as a 
contributory factor would have both the code for bronchitis and the code for SHS 
exposure recorded.  E codes should not be assigned in the absence of a condition or 
symptom. E codes are never permitted to be in the principal/first-listed code position. 
When the ICD-10-CM version was introduced in October 2015, the code for SHS 
exposure became Z77.22, Contact with and exposure to environmental tobacco smoke, 
acute or chronic. 
Understanding that the use of the diagnostic code for SHS could hinder sales, 
Philip Morris, a tobacco company, spent $2.2 million in an effort to stop the SHS code 
implementation in a project that was called ICD-9 Project43. A large portion of the 
money was given to a lobbying firm, Multinational Business Services (MBS), to carry 
out the plan. Philip Morris encouraged physicians, public health professionals, and others 
to urge the National Center for Health Statistics (NCHS) to abandon the implementation 
of the ICD-9-CM code for SHS. Philip Morris and MBS also attempted to get the 
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government to switch from ICD E codes to the Nordic Medico Statistical Committee 
(NOMESCO) model to describe injuries. They suggested that the NOMESCO model 
reduced uncertainty in coding.  
Philip Morris and MBS were not successful in eliminating the SHS E Code. But 
in 1995, they did succeed in making the new SHS E code invalid for use on the Medicare 
billing form which was required to be used for all requests for payment of provider 
services43. Known as Centers for Medicare and Medicaid Services (CMS) Form 1500, the 
Medicare/Medicaid billing form, is used by physicians and Allied Health Professionals to 
bill for services they provide43. In 2006, when CMS Form 1500 was up for renewal, the 
code was permitted. Philip Morris was no longer able to thwart its use. Statistical data 
from physician billing between 1995 and 2006 were lost due to Philip Morris’ efforts. 
During these years, however, not all data were lost. The use of SHS E codes continued to 
be permitted on claim forms used by hospitals and other health care facilities.  
   
 Challenges with Insurance Coverage 
A partnership that was formed in 2017 with the CDC, health care purchasers, 
payers, and providers was designed to improve the health of the nation and to control 
health care costs. Known as the 6/18 Initiative, the project targets six health conditions 
which are known to be complex and high cost conditions. They include tobacco use, 
hypertension, healthcare-associated infections, asthma, unintended pregnancies, and 
diabetes.  
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The 6/18 initiatives includes 18 tobacco cessation interventions44. The proven 
interventions for reducing tobacco use include counseling on an individual and group 
level using both in-person and telephonic counseling techniques, as recommended in the 
2008 Public Health Service Clinical Practice Guidelines. The 6/18 program encourages 
the implementation of cost sharing and assistance with insurance authorization for 
smoking cessation products such as medications. The program encourages that insurers 
expand the coverage for smoking cessation in employee insurance benefit coverage44. 
The CDC is providing direct assistance to payers such as state Medicaid programs 
and employee-based insurers to implement tobacco cessation programs and insurance 
coverage programs to pay for the benefit. They are also working with provider networks 
throughout the nation to be able to help their physician members learn how about the 
services that are available, how to offer the interventions such as smoking cessation, and 
get paid for the services they provide for their patients. The advocacy and support of the 
CDC can help to further ease the burden that physicians face in delivering the care that 
they know their patients need.  
One of the major barriers is the inability for individuals to afford the cost of 
tobacco cessation medications and provider office bills. The CDC 6/18 Initiative 
emphasizes the need to reduce the out-of-pocket costs associated with nicotine 
replacement therapy (NRT) and other interventions to quit smoking, based on research 
studies that document the positive impact on quit rates45. One such study published in the 
American Journal of Preventive Medicine, demonstrated that an outreach program 
offering free tobacco cessation to smokers in a community health center was a cost-
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effective way to increase NRT. The outreach program also increased short-term quit 
rates. In the study, free NRT and counseling nearly doubled smokers’ likelihood of using 
pharmacotherapy. Free NRT also more than tripled their odds of using NRT. The study 
did not increase the use of counseling or other medications used for smoking cessation. 
Self-reported tobacco cessation was achieved for the past seven days and 30 days at 3-
month follow-up mark46. 
 The 6/18 Initiative reported the status of insurance coverage as of March 2017. 
The Medicare program covers individual cessation counseling, but does not cover group 
or telephone counseling. The cost-sharing requirement for counseling varies based on 
whether the individual has smoking-related disease; those who have already developed a 
smoking-related disease may be subject to cost-sharing and those without disease have no 
cost. Medicare covers prescription medications only. For the Medicaid program, the 
coverage for counseling and tobacco cessation products varies by state. States can receive 
financial incentives if they cover tobacco cessation services. Coverage varies by payer in 
the private and commercial insurance markets.  
 
 Medical Education 
 Medical school provides an opportunity for medical students to learn the 
fundamentals so they can apply their knowledge in caring for patients and their families 
upon graduation. Based on a national survey of 4,756 allopathic and osteopathic 
physicians trained in allopathic residencies, Cantor et al. (1993)47 found that medical 
schools produce physicians who are adequately prepared to manage the physical 
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conditions that patients experience. Physicians did not, however, feel adequately prepared 
to manage the behaviors that produce chronic disease and the social context of disease. 
Physicians also did not feel prepared to teach patients how to prevent diseases. Only 21 
percent of physician respondents reported that their formal medical education from 
medical school through residencies and fellowships prepared them in an “excellent” or 
“good” manner to assist smokers to stop smoking. The remaining 79 percent report their 
training in this area was “fair” or “poor”. 
  Ferry et al. (1999)48 reported on a survey sent to 126 associate deans for medical 
education from across the country. The survey included questions on basic science such 
as the health effects of tobacco and SHS, the composition of tobacco smoke, and the 
effect of tobacco in high risk populations. The survey also included questions related to 
the clinical care provided by physicians to assess and treat tobacco use and reduce SHS 
exposure. The number of medical school class hours offered each year were also queried. 
 Fifty five percent of medical schools included all basic science components, but 
only four percent of medical schools included all of the components related to the clinical 
care of patients. Tobacco content was included among many other topics in both required 
courses and elective courses. Twenty of 119 schools (16.8%) that completed the question 
reported that they did not require any tobacco cessation training at all. Three schools 
(2.4%) had a required course dedicated to tobacco cessation. The study concluded that 
graduates of medical school were not adequately prepared to address tobacco dependence 
and a national core curricula should be implemented in all United States medical schools. 
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A group of representatives from Boston University Medical School, the lead 
medical school, and 11 other medical schools throughout the nation collaborated to 
examine the medical student curriculum content related to tobacco assessment, 
prevention, and treatment at their schools49. The researchers believed training medical 
students was vital to producing physicians who would be able to confront the morbidity 
and mortality that was evident with tobacco use. The program, known as the Tobacco 
Prevention and Cessation Education (PACE) program, was funded by the NCI and 
included a survey that was administered in 2003 to assess each school’s curriculum 
related to tobacco use prevention and tobacco cessation. 
 The survey, which was completed by faculty members and medical school 
administrators, asked about the content related to tobacco, practitioner skills needed for 
tobacco cessation, curricular evaluation, perceptions of the faculty about program 
barriers, and the vision of the program. All medical school courses at each school were 
considered. Findings indicated that 36 percent of courses at the 12 medical schools had 
some content that involved tobacco. The number of course hours that included tobacco 
content were added at each medical school. All schools had more than four total hours. 
Five schools (41.7%) had four to eight hours, five schools (41.7%) had 10 to 13 hours, 
and two schools (16.7%) provided 17 to 18 hours of education. Most of the school 
clerkships had less hours of tobacco content as compared to first year courses. Only two 
of 12 schools (16.7%) had content in obstetrics and gynecology clerkships and four of 12 
schools (33.3%) had content in pediatric clerkships. Although the number of courses and 
hours dedicated to tobacco content in this 2003 study was higher than past reports, the 
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study identified opportunity for improvement. While courses focused on tobacco 
cessation for users of tobacco, a need to focus on tobacco use prevention was identified. 
 More recently, in 2014, the MSQuit trial (i.e., Medical Students helping patients 
Quit tobacco) was implemented to determine if tobacco educational intervention 
improved tobacco dependence treatment skills among medical students50. The 
educational interventions included multi-modal educational intervention compared to 
traditional education. The treatment skills included the 5As Approach to tobacco 
cessation, including Ask, Advise, Assess, Assist, and Arrange Follow-up. The MSQuit 
Trial compared multi-modal educational intervention with traditional education in ten 
medical schools throughout the United States. Traditional education included standard 
didactic lectures, while multi-modal education included standard didactic education and a 
web-based course in the first medical school year and preceptor facilitated training during 
a clerkship rotation in the third medical school year. The Objective Structured Clinical 
Examination (OSCE), a tool that assesses competency applying the 5As Approach though 
direct observation, was the outcome measure51. The study determined that multi-modal 
education prepared medical students in tobacco dependence treatment than did traditional 
didactic education. 
In its 2015 Position Paper entitled Tobacco: Preventing and Treating Nicotine 
Dependence and Tobacco Use, the AAFP encouraged the nation’s medical schools and 
hospital residency programs to effectively educate medical students and residents in the 
prevention of tobacco use and also in tobacco cessation52. Research findings and medical 
society recommendations strongly advocate for education of medical students on tobacco 
33 
 
cessation. Available evidence and recommendations are not yet customized to medical 
student educational strategies for particular patient ages and racial/ethnic disparities that 
exist. 
 
 Specific Challenges with Youths 
 Youths rely on others to protect them from harm. They are often too young to 
provide assessment data on smoke and vapor exposure that physicians need to determine 
a plan of care. Physicians need to rely on answers provided by parents, family members, 
and guardians to questions such as smoke and vapor exposure. Pediatricians, family 
physicians, and others provide smoking cessation advice to parent, family members, and 
guardians and hope that the advice translates into action that keeps their young patients 
safe.  
 Research shows that youths still have high rates of SHS exposure and racial 
disparities continue to exist23. Data suggests that additional work is needed to improve 
the rate of SHS exposure in youths overall and in non-Hispanic blacks in particular. 
Specific methods to educate medical students and trained medical professionals to 
manage the nuances of youths overall and youths of various races and ethnicities is also 
needed. 
  
Conclusion 
 The negative effect of SHS exposure in youths is clearly reported in the literature. 
Middle ear disease, respiratory illnesses, and SIDS are conditions experienced by youths 
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exposed to SHS. Research has shown that the prevalence of SHS exposure in youths has 
declined over time, but opportunities exist to reduce SHS exposure even more. Research 
data from recent years demonstrates that youths from low socioeconomic families and 
minority youths have higher SHS exposure than white/non-Hispanic youths. Research 
related to e-cigarette vapor exposure is in its infancy. More work is needed to understand 
the effect of vapor on youths from all racial and ethnic backgrounds. 
The work of the Surgeon General, federal organizations such as the CDC and 
NIH, and medical professional societies have been instrumental in examining and 
reporting the dangers of SHS exposure. They have also been instrumental in providing a 
smoking cessation framework to be used by medical providers when they care for 
patients in their offices and other health care settings. The ASK and ACT approach, for 
example, includes the specific questions that providers should ask and the specific 
interventions that providers should implement based on the answers to questions. The 
ASK and ACT approach takes physicians’ time to implement, however, physicians are 
not compensated by all insurance companies for the time it takes to perform these 
activities well. The approaches do not yet take into account the differences in assessment 
and treatment that may be needed to have more impact on particular races and ethnicities. 
There is not yet consistency in the medical education of future physicians. Each 
medical school determines the courses they require student to complete and also 
determine courses offered on an elective basis. Courses with tobacco content can range 
from no tobacco content on one extreme to a required class dedicated to tobacco on 
another extreme. Without a standard approach, there is no way to ensure new physicians 
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are competent to prevent tobacco use in their patients and reduce tobacco use through 
smoking cessation. Many new physicians need to rely on information provided by their 
professional societies such as AAP and AAFP, research literature, and position papers 
from the Surgeon General, NCI, CDC, and other organizations. 
Physicians must continue to advocate for youths on multiple levels, including one 
on one with patients in their offices, at the local level in their communities, and at the 
national level through legislative advocacy and insurance reform. They must continue to 
eliminate the barriers to reducing SHS and vapor exposure in youths by 1) advocating for 
the use of diagnostic codes by physicians to record SHS and vapor exposure in medical 
records and databases; 2) encouraging the appropriate insurance payment to medical 
providers who spend time with patients and their families to counsel them about smoking 
cessation and eliminating SHS and vapor exposure; and 3) advocating for the consistent 
inclusion of tobacco and vapor content in the medical education of future physicians. 
Physicians must continue to conduct research studies to expand the knowledge base of 
SHS and vapor exposure and protect youths from the dangers of both.   
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